Cargando…

Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

Detalles Bibliográficos
Autores principales: Hottinger, A F, Ben Aissa, A, Espeli, V, Squiban, D, Dunkel, N, Vargas, M I, Hundsberger, T, Mach, N, Schaller, K, Weber, D C, Bodmer, A, Dietrich, P-Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877431/
https://www.ncbi.nlm.nih.gov/pubmed/29315292
http://dx.doi.org/10.1038/bjc.2017.469
_version_ 1783310696787738624
author Hottinger, A F
Ben Aissa, A
Espeli, V
Squiban, D
Dunkel, N
Vargas, M I
Hundsberger, T
Mach, N
Schaller, K
Weber, D C
Bodmer, A
Dietrich, P-Y
author_facet Hottinger, A F
Ben Aissa, A
Espeli, V
Squiban, D
Dunkel, N
Vargas, M I
Hundsberger, T
Mach, N
Schaller, K
Weber, D C
Bodmer, A
Dietrich, P-Y
author_sort Hottinger, A F
collection PubMed
description
format Online
Article
Text
id pubmed-5877431
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58774312018-04-05 Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma Hottinger, A F Ben Aissa, A Espeli, V Squiban, D Dunkel, N Vargas, M I Hundsberger, T Mach, N Schaller, K Weber, D C Bodmer, A Dietrich, P-Y Br J Cancer Corrigendum Nature Publishing Group 2018-03-20 2018-01-09 /pmc/articles/PMC5877431/ /pubmed/29315292 http://dx.doi.org/10.1038/bjc.2017.469 Text en Copyright © 2018 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Corrigendum
Hottinger, A F
Ben Aissa, A
Espeli, V
Squiban, D
Dunkel, N
Vargas, M I
Hundsberger, T
Mach, N
Schaller, K
Weber, D C
Bodmer, A
Dietrich, P-Y
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
title Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
title_full Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
title_fullStr Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
title_full_unstemmed Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
title_short Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
title_sort phase i study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877431/
https://www.ncbi.nlm.nih.gov/pubmed/29315292
http://dx.doi.org/10.1038/bjc.2017.469
work_keys_str_mv AT hottingeraf phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT benaissaa phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT espeliv phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT squiband phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT dunkeln phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT vargasmi phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT hundsbergert phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT machn phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT schallerk phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT weberdc phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT bodmera phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma
AT dietrichpy phaseistudyofsorafenibcombinedwithradiationtherapyandtemozolomideasfirstlinetreatmentofhighgradeglioma